Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Imaging Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Clinical Trial Imaging Market Outlook ... Read More
-
Clinical Trials Support Services Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... size poised to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Clinical Trials Support ... Read More
-
Non-Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... period with a CAGR of 6.22%through 2028. The Global Non-Clinical Trials Market represents a dynamic and essential component of the pharmaceutical and healthcare industries, playing a pivotal role in the development and approval of new ... Read More
-
RNA Therapy Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... experience substantial growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 5.06% and expected to reach USD 3.49 Billion through 2028. RNA therapy, a cutting-edge field of medical research, has ... Read More
-
Clinical Trial Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
... biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.6% ... Read More
-
Clinical Trials Matching Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... growth in the forecast period with a CAGR of 8.59% through 2028. Pharmaceutical companies, biotechnology firms, clinical research organizations (CROs), and medical device manufacturers routinely conduct clinical trials to assess the safety and efficacy of ... Read More
-
Virtual Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease, Others), By Phase (Phase 1, Phase 2, Phase 3, Phase 4), By Region, Competition
... 3, Phase 4), By Region, Competition The Global Virtual Clinical Trials Market was valued at USD 7.12 Billion in 2022 and is projected to experience strong growth during the forecast period, with a compound annual ... Read More
-
Computational Biology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), By Tool (Databases, Infrastructure (Hardware), Analysis Software and Services), By Service (In-house, Contract), By End User (Academics, Industry and Commercials), By Region, By Competition Forecast & Opportunities, 2018-2028F
... in the coming years, with a projected Compound Annual Growth Rate (CAGR) of 7.44% through 2028. The Global Cytokine Market represents a dynamic and rapidly evolving sector within the pharmaceutical and biotechnology industries. Cytokines, a ... Read More
-
Diabetic Neuropathic Pain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... is a dynamic and rapidly evolving sector within the broader healthcare industry, characterized by a growing prevalence of diabetes worldwide. Diabetic neuropathic pain is a distressing and debilitating complication of diabetes mellitus, affecting a significant ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Chronic Lymphocytic Leukemia (CLL). These sales forecasts leverage data on ... Read More
-
Inhalable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... Path and Key Companies, 2023 Update provides comprehensive information about the Inhalable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are ... Read More
-
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Acute Myeloid Leukemia (AML). These sales forecasts leverage data ... Read More
-
Batten Disease (BD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... markets, GlobalData estimates that there are 8,537 diagnosed prevalent cases of BD in 2023 and the number is expected to increase to 8,717 cases by 2028. The marketed space for BD treatment is limited only ... Read More
-
Global Goitre Treatment Market - 2023-2030
... period 2023-2030. The global goitre treatment market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics such as increasing prevalence, rising clinical trials, research activities, and others. Government investments ... Read More
-
Global Chronic Inflammation Treatment Market - 2023-2030
... during the forecast period 2023-2030. The chronic inflammation treatment market trends show rising product launches owing to the rising technological advancements. Inflammation that lasts for a few months to years is known as chronic inflammation ... Read More
-
Clinical Trials Feasibility Risk Assessment and Planning for Success - A Depression Case Study
... to run similar trials successfully. As the prevalence of depression has increased, the outlook of it has also changed in positive ways. Better support and services for depression as well as the increase of discussing ... Read More
-
Global Pharmaceutical and Life Science Outsourcing Services Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... characteristics, and market growth of the Pharmaceutical and Life Science Outsourcing Services industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Pharmaceutical and ... Read More
-
Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Lennox-Gastaut Syndrome. Report includes an ... Read More
-
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cutaneous Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus ... Read More
-
Meningitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Sponsor Type and Top Countries, 2023 Update provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report includes an overview of trial numbers ... Read More
-
Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Myelodysplastic Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Myelodysplastic Syndrome. Report includes an ... Read More
-
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Turner Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Turner Syndrome. Report includes an ... Read More
-
Keratoconjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Sponsor Type and Top Countries, 2023 Update provides an overview of Keratoconjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconjunctivitis. Report includes an overview of trial numbers ... Read More
-
Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Gaucher Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an ... Read More
-
Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More